19th week of 2014 patent applcation highlights part 53 |
Patent application number | Title | Published |
20140128568 | METHOD FOR MANUFACTURING POLYARYLENE SULFIDE RESIN - A method for producing a polyarylene sulfide resin, comprising: producing a slurry (I) containing a solid alkali metal sulfide by allowing a hydrous alkali metal sulfide, or a hydrous alkali metal hydrosulfide and an alkali metal hydroxide, and an aliphatic cyclic compound (c1) that can be ring-opened by hydrolysis to react with each other while conducting dehydration in the presence of a non-hydrolyzable organic solvent; adding an aprotic polar organic solvent after the production of the slurry (I) and distilling off water to conduct dehydration; and conducting polymerization by allowing a polyhaloaromatic compound (a), an alkali metal hydrosulfide (b), and an alkali metal salt (c2) of a hydrolysate of the compound (c1) to react with each other in the slurry (I) in a state where the amount of water existing in the reaction system is 0.02 moles or less relative to 1 mole of the aprotic polar organic solvent. | 2014-05-08 |
20140128569 | METHOD FOR ACQUIRING A HEAT-STABLE ANTIBODY-DISPLAYED PHAGE - Using a biopanning method, a heat-stable antibody-displayed phage is acquired. More particularly, first, an antibody-displayed phage library aqueous solution containing plural types of antibody-displayed phages is supplied to a support comprising a polypeptide on the surface thereof, so as to bind the plural types of the antibody-displayed phages to the polypeptide specifically. Next, the support is heated to the temperature of not less than 37 degrees Celsius and not more than 70 degrees Celsius, so as to release a portion of the antibody-displayed phages from the support and so as to leave the other antibody-displayed phages on the support selectively. Finally, the other antibody-displayed phages which has been left on the support selectively in the previous step is collected to obtain the heat-stable antibody-displayed phage. | 2014-05-08 |
20140128570 | CONFORMATIONALLY-PREORGANIZED, MINIPEG-CONTAINING GAMMA-PEPTIDE NUCLEIC ACIDS - The present invention relates to γ-PNA monomers according to Formula I where substituent groups R | 2014-05-08 |
20140128571 | AROMATIC COMPOUNDS WITH SULFUR CONTAINING LIGANDS - Compounds useful as nutritional supplements, antioxidants, heavy metal chelators and/or as intermediates for producing other related compounds with like uses have a formula: | 2014-05-08 |
20140128572 | Process For Extraction Of Peptides And Its Application In Liquid Phase Peptide Synthesis - A process for extraction of a peptide from a reaction mixture resulting from a peptide coupling reaction, the reaction mixture containing the peptide and a polar aprotic solvent selected from N,N-dimethylformamide, N,N-dimethylacetamide and N-methyl-2-pyrrolidone, whereby the process includes a step a) and a step b): step a) including the addition of a component a1), a component a2) and a component a3), whereby component a1) is an organic solvent 1, the organic solvent 1 is selected from 2-methyltetrahydrofuran and toluene, component a2) is water, and component a3) is an organic solvent 2, the organic solvent 2 is selected from the ethylacetate, isopropylacetate, acetonitrile, tetrahydrofuran and n-heptane to the reaction mixture, so that a biphasic system with an organic layer and an aqueous layer is obtained; step b) including the subsequent separation of the organic layer containing the peptide from the aqueous layer. The extraction step is preferably used in a process for preparation of a peptide in liquid phase. | 2014-05-08 |
20140128573 | METHOD FOR PRODUCING COLLAGEN-LIKE POLYPEPTIDE - An object is to provide a method for producing an ever-larger molecular weight collagen-like polypeptide single strand. Another object is to provide a method for controlling a molecular weight of a product to be obtained in desired magnitude upon producing a collagen-like polypeptide single strand. A solution is a method for producing a polypeptide including a step for allowing a condensation reaction of peptide oligomers represented by any one of formulas (1) to (3) (SEQ ID No:1 to SEQ ID No:3), wherein the condensation reaction is carried out in an aqueous solvent containing a phosphate ion in the range of 0 M to less than 0.01 M in the presence of a condensing agent, or a condensing agent and a condensing auxiliary: | 2014-05-08 |
20140128574 | PROTEIN HYDROLYZATE AND PROCESSES FOR THE PRODUCTION THEREOF - Protein concentrates and protein isolates, in addition to processes for the production of protein concentrates hydrolyzates thereof and protein isolates, are disclosed. In particular, the disclosure relates to a process for removing fiber from an oilseed meal, comprising:
| 2014-05-08 |
20140128575 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES - The invention concerns methods and means for preventing the reduction of disulfide bonds during the recombinant production of disulfide-containing polypeptides. In particular, the invention concerns the prevention of disulfide bond reduction during harvesting of disulfide-containing polypeptides, including antibodies, from recombinant host cell cultures. | 2014-05-08 |
20140128576 | Anti-IL-23 Antibodies, Compositions, Methods and Uses - An anti-IL-23 antibody, including isolated nucleic acids that encode at least one anti-IL-23 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices. | 2014-05-08 |
20140128577 | PURIFICATION OF CHIMERIC PROTEIN - Provided is a method for purification of TNFR:Fc fusion protein comprising hydrophobic interaction chromatography, wherein the buffer solution used in the said chromatography does not contain any additives. | 2014-05-08 |
20140128578 | SELECTIVE ENRICHMENT OF ANTIBODIES - The invention relates to a process for the selective concentration of immunoglobulins or other proteins that contain an Fc domain (target protein), comprising the following steps:
| 2014-05-08 |
20140128579 | SPECIFIC DELIVERY OF AGROCHEMICALS - Described is the specific delivery of agrochemicals to plants. More specifically, a targeting agent has at least one binding domain that specifically binds to a binding site on an intact living plant. Such binding domains include a peptide having 4 framework regions and 3 complementary determining regions, or fragment(s) thereof, wherein the binding domains bind or retain a carrier onto a plant. Described are binding domains that specifically bind trichomes, stomata, cuticle, lenticels, thorns, spines, root hairs, or wax layer. Further described are methods for delivering agrochemicals to a plant, for depositing agrochemicals on a plant, and for retaining the agrochemicals on a plant, using targeting agents comprising the binding domains, and to methods for protecting a plant against stress or controlling plant growth. Also, described are methods for manufacturing a specifically targeting agrochemical carrier. | 2014-05-08 |
20140128580 | ANTIBODY-DRUG CONJUGATES AND METHODS - The present invention relates to antibody-drug conjugate compounds of Formula I: | 2014-05-08 |
20140128581 | DISUBSTITUTED AMINO ACIDS AND METHODS OF PREPARATION AND USE THEREOF - Provided are crystalline α, α-disubstituted amino acids and their crystalline salts containing a terminal alkene on one of their side chains, as well as optionally crystalline halogenated and deuterated analogs of the α, α-disubstituted amino acids and their salts; methods of making these, and methods of using these. | 2014-05-08 |
20140128582 | CONTINUOUS PREPARATION METHOD OF GINSENG GINSENOSIDES AND POLYSACCHARIDES - The present invention provides a continuous preparation method of | 2014-05-08 |
20140128583 | ERYTHROMYCIN ETHYLSUCCINATE CRYSTALLINE HYDRATE, PREPARATION AND USES THEREOF - Disclosed is an anti-infective drug-macrolide derivate, preparation and uses thereof. Macrolide derivate, namely erythromycin ethylsuccinate crystalline hydrate, which has less moisture absorption and good storage stability, can be used in the preparation of medicaments for the treatment and prevention of human or animal infectious diseases caused by Gram-positive or negative bacteria. | 2014-05-08 |
20140128584 | Disubstituted Maleic Anhydrides with Altered Kinetics of Ring Closure - We describe anhydride compounds suitable for physiologically labile modification of amine-containing molecules. The described anhydrides form reversible linkages having desirable kinetics for in vivo delivery of biologically active molecules. Also described are endosomolytic polymers formed by modification of membrane active polyamines with the described anhydrides. | 2014-05-08 |
20140128585 | FRUCTOSE ABSORPTION INHIBITOR - A fructose absorption inhibitor according to the present invention comprises a hydrolyzable tannin as an active ingredient. The hydrolyzable tannin preferably has a form composed of a gallic acid derivative and/or an ellagic acid derivative bound to a hydroxy group in glucose via an ester bond, and includes ellagitannin, gallotannin and so on. | 2014-05-08 |
20140128586 | AMINO-LNA, THIO-LNA AND ALPHA-L-OXY-LN - A novel class of pharmaceuticals which comprises a Locked Nucleic Acid (LNA) which can be used in antisense therapy. These novel oligonucleotides have improved antisense properties. The novel oligonucleotides are composed of at least one LNA selected from beta-D-thio/amino-LNA or alpha-L-oxy/thio/amino-LNA. The oligonucleotides comprising LNA may also include DNA and/or RNA nucleotides. | 2014-05-08 |
20140128587 | NUCLEIC ACID MODULATORS OF GLYCOPROTEIN VI - The present invention relates, in general, to a pharmacologic system to modulate the biology of platelets based upon a nucleic acid ligand that can interact with and modulate the activity of platelet glycoprotein GPVI to regulate platelet function. These nucleic acid ligands are also actively reversible using a modulator that inhibits the activity of the nucleic acid ligand to neutralize this pharmacologic effect and thereby restore GPVI function, including collagen binding, platelet adhesion, collagen-induced platelet activation, and collagen-induced platelet aggregation. The invention further relates to compositions comprising the nucleic acid ligand, the ligand and a modulator, methods to generate the nucleic acid ligand and its modulator, as well as methods of using these agents and compositions in medical therapeutic and diagnostic procedures. | 2014-05-08 |
20140128588 | COMPOSITIONS OF MATTER THAT REDUCE PAIN, SHOCK, AND INFLAMMATION BY BLOCKING LINOLEIC ACID METABOLITES AND USES THEREOF - A method for treating and/or diagnosing pain and the source or type of pain, shock, and/or inflammatory conditions in a subject. A method of using a therapeutically effective amount of a DNA or RNA aptamer that shows high affinity for OLAMs to at least partially treat pain, shock, and/or inflammatory conditions in a subject. The DNA or RNA aptamer that shows high affinity for OLAMs may be coupled to a plasma protein binding compound or a pharmacologically active agent. A method of treating and or diagnosing pain, shock, and/or inflammatory conditions in a subject may include inactivating or preventing at least one linoleic acid metabolite to treat certain conditions (e.g., pain, shock, and/or inflammation) using a DNA or RNA aptamer that shows high affinity for OLAMs. | 2014-05-08 |
20140128589 | METHOD FOR EVALUATING REDOX ACTIVITY OF NUCLEIC ACID MOLECULE AND NUCLEIC ACID MOLECULE HAVING REDOX ACTIVITY - The present invention provides a novel technique by which the redox activity of a nucleic acid molecule can be evaluated. An evaluation method of the present invention includes: a detection step of electrochemically detecting a redox reaction to a substrate, the redox reaction being catalyzed by a nucleic acid molecule to be evaluated, using a device that electrochemically detects a redox reaction; and an evaluation step of evaluating redox activity of the nucleic acid molecule from a result of the detection of the redox reaction. As the device, a device in which a base provided with a detection portion is included, the detection portion. | 2014-05-08 |
20140128590 | HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM - The invention provides hydrolases, polynucleotides encoding them, and methods of making and using these polynucleotides and polypeptides. In one aspect, the invention is directed to polypeptides, e.g., enzymes, having a hydrolase activity, e.g., an esterase, acylase, lipase, phospholipase (e.g., phospholipase A, B, C and D activity, patatin activity, lipid acyl hydrolase (LAH) activity) or protease activity, including thermostable and thermotolerant hydrolase activity, and polynucleotides encoding these enzymes, and making and using these polynucleotides and polypeptides. The hydrolase activities of the polypeptides and peptides of the invention include esterase activity, lipase activity (hydrolysis of lipids), acidolysis reactions (to replace an esterified fatty acid with a free fatty acid), transesterification reactions (exchange of fatty acids between triglycerides), ester synthesis, ester interchange reactions, phospholipase activity and protease activity (hydrolysis of peptide bonds). The polypeptides of the invention can be used in a variety of pharmaceutical, agricultural and industrial contexts, including the manufacture of cosmetics and nutraceuticals. In another aspect, the polypeptides of the invention are used to synthesize enantiomerically pure chiral products. | 2014-05-08 |
20140128591 | ANTISENSE DESIGN - A novel class of pharmaceuticals which comprises a Locked Nucleic Acid (LNA) which can be used in antisense therapy. These novel oligonucleotides have improved antisense properties. The novel oligonucleotides are composed of at least one LNA selected from beta-D-thio/amino-LNA or alpha-L-oxy/thio/amino-LNA. The oligonucleotides comprising LNA may also include DNA and/or RNA nucleotides. | 2014-05-08 |
20140128592 | METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA - The invention relates to a method for inducing or promoting skipping of exon 45 of DMD pre-mRNA in a Duchenne Muscular Dystrophy patient, preferably in an isolated (muscle) cell, the method comprising providing an isolate muscle cell with a molecule that binds to a continuous stretch of at least 21 nucleotides within said exon. The invention further relates to such molecule used in the method. | 2014-05-08 |
20140128593 | SYNTHESIS OF 5-AZACYTIDINE - Provided herein are processes for the preparation of 5-azacytidine, useful for treating, preventing, and/or managing diseases or conditions including cancer, disorders related to abnormal cell proliferation, hematologic disorders, and myelodysplastic syndromes (MDS), wherein 5-azacytidine is represented by the structure: | 2014-05-08 |
20140128594 | Method for Manufacturing Hydroxyethyl Starch Derivatives - A method for manufacturing a modified hydroxyethyl starch carrying a heptonic acid residue on at least one of its termini is disclosed. Within this method, the following steps are carried out: a) dissolving hydroxyethyl starch in water, b) adjusting the pH value to a value of 8.0 to 10.0, c) adding a cyanide compound to the hydroxyethyl starch solution, heating the solution to a temperature of 80 to 99° C. and keeping it at this temperature for a first time period, and d) adjusting the pH value to a value of 2.0 to 4.0, bringing the solution to a temperature of 50 to 90° C. and keeping it at this temperature for a second time period. | 2014-05-08 |
20140128595 | Process for the Preparation of -C-Aryl Glucosides - The present invention provides processes for stereoselectively preparing C-arylglucosides that can be useful as synthetic building block or drugs, including SGLT2 inhibitors. | 2014-05-08 |
20140128596 | CROSSLINKED POLYSACCHARIDE - This invention relates to a detection system for measuring a fluorescent signal in a fluorescent assay. The system comprises a probe having a small sensing surface bound with a fluorescent label, and a light source and a detector both mounted at the proximal side of the sensing surface of the substrate. The invention also relates to a method for detecting an analyte in a liquid sample using a probe tip having a small surface area (≦5 mm) and a high molecular weight polymer (≧1 MD) having multiple binding molecules and multiple fluorescent labels. The binding reaction is accelerated by flowing the reaction solutions laterally and moving the probe tip up and down in the reaction vessels. The invention furthers relates to a fluorescent labeling composition comprising a cross-linked FICOLL® molecule having a plurality of binding molecules and a plurality of fluorescent labels. | 2014-05-08 |
20140128597 | POLYSACCHARIDE DERIVATIVE AND SEPARATING AGENT FOR OPTICAL ISOMER CONTAINING THE SAME - The present invention provides: a polysaccharide derivative containing a structure wherein hydrogen atoms in a hydroxyl group at the 2-position and the 3-position of a structure unit of polysaccharide are substituted with different substituents respectively represented by a specific general formula; and, a separating agent for optical isomers, which contains such a polysaccharide derivative. The present invention can provide a novel polysaccharide derivative which has excellent optical isomer separating ability, and is thus suitable for a separating agent for optical isomers, and can provide a separating agent for optical isomers which contains the polysaccharide derivative. | 2014-05-08 |
20140128598 | PROCESS FOR THE SYNTHESIS OF (2E)-3-(3,4-DIMETHOXYPHENYL)PROP-2-ENENITRILE, AND APPLICATION IN THE SYNTHESIS OF IVABRADINE AND ADDITION SALTS THEREOF WITH A PHARMACEUTICALLY ACCEPTABLE ACID - Process for the synthesis of the compound of formula (I): | 2014-05-08 |
20140128599 | BENZOXAZOLE KINASE INHIBITORS AND METHODS OF USE - The present invention provides chemical entities or compounds and pharmaceutical compositions thereof that are capable of modulating certain protein kinases such as mTor, tyrosine kinases, and/or lipid kinases such as PI3 kinase. Also provided in the present invention are methods of using these compositions to modulate activities of one or more of these kinases, especially for therapeutic applications. | 2014-05-08 |
20140128600 | METHODS FOR PREPARING NAPHTHYRIDINES - The present invention provides methods of synthesizing compounds of formula (1) and intermediates thereto. The present invention also provides intermediates useful in the synthesis of compounds of formula (1). | 2014-05-08 |
20140128601 | PROCESS FOR OBTAINING RIVAROXABAN AND INTERMEDIATE THEREOF - This invention relates to a procedure for obtaining a thiophene-2-carboxamide compound, specifically rivaroxaban, which comprises the (i) fragmentation of the N═C bond of a compound of formula 23 where R1 is selected among hydrogen, halogen, and (C1-C6)alkyl; and (ii) acylation of the resulting intermediate with 5-chloro-tiofen-2-carbonyl chloride in a solvent medium, in the presence of a base. The invention also relates to the compounds of formula 23 and their use in the obtention of rivaroxaban. | 2014-05-08 |
20140128602 | METHODS FOR PREPARING ANTI-VIRAL NUCLEOTIDE ANALOGS - Methods for isolating 9-{(R)-2-[((S)—{[(S)-1-(isopropoxycarbonyl)ethyl]amino}phenoxyphosphinyl)methoxy]propyl}adenine (compound 16): | 2014-05-08 |
20140128603 | FUSED PYRIMIDINE-DIONE DERIVATIVES AS TRPA1 MODULATORS - The invention described herein relates to novel fused pyrimidinediones derivatives of formula (I) which are TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). This invention also provides processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1. | 2014-05-08 |
20140128604 | 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS - The present invention relates to substituted xanthines of general formula | 2014-05-08 |
20140128605 | CRYSTALS OF GLYCINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF - A crystal of (S,E)-2-(2,6-dichlorobenzamido)-5-[4-(methyl-pyrimidin-2-ylamino)phenyl]pent-4-enoic acid has excellent chemical and physical stability, and a medical use thereof. | 2014-05-08 |
20140128606 | ANTIPRURITIC AGENT - An antipruritic which exerts an antipruritic effect based on a novel action mechanism and is effective for pruritus. The antipruritic contains as an effective ingredient a compound which activates a central type nicotinic acetylcholine receptor. | 2014-05-08 |
20140128607 | PROCESSES FOR THE PREPARATION OF SITAGLIPTIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF - There is provided salts and polymorphs of sitagliptin, processes for the preparation thereof, and pharmaceutical compositions comprising the same. | 2014-05-08 |
20140128608 | PROCESS FOR PREPARING PHOTORESPONSIVE HYBRID ORGANIC-INORGANIC PARTICLES - A process for preparing photoresponsive hybrid organic-inorganic particles comprises (a) combining (1) at least one organosilane compound comprising at least two silicon-bonded groups selected from hydroxyl groups, hydrolyzable groups, and combinations thereof and (2) at least one neat photoactive material, to form a ceramic precursor composition; and (b) allowing or inducing hydrolysis of the hydrolyzable groups and condensation of the organosilane compound to form hybrid organic-inorganic particles comprising the photoactive material. | 2014-05-08 |
20140128609 | PYRROLOQUINOLINE QUINONE DISODIUM SALT CRYSTAL AND METHOD FOR PRODUCING THE SAME - An object of the present invention is to provide a novel pyrroloquinoline quinone disodium crystal having excellent dispersibility in solvents and excellent permeability through skin, and a method for producing the pyrroloquinoline quinone disodium crystal with high efficiency. According to the present invention, provided are a novel pyrroloquinoline quinone disodium crystal which is produced by drying a crystal produced under specified conditions through a drying means such as lyophilization, ambient drying and vacuum drying, and a method for producing the pyrroloquinoline quinone disodium crystal. | 2014-05-08 |
20140128610 | R-7-(3-AMINOMETHYL-4-METHOXYIMINO-3-METHYL-PYRROLIDIN-1-YL)-1-CYCLOPROPYL-- 6-FLUORO-4-OXO-1,4-DIHYDRO-[1,8]NAPHTHYRIDINE-3-CARBOXYLIC ACID AND L-ASPARTIC ACID SALT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FOR ANTIMICROBIAL - Disclosed herein are R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial. Because the R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and L-aspartic acid salt is more soluble and less toxic and has less side effects as an antimicrobial agent than hydrochloride and the other salts (D-aspartate and phosphate) conventionally used, the salt may be useful for oral and injectable administration. | 2014-05-08 |
20140128611 | METHOD FOR MANUFACTURING OXETANE COMPOUND, METHOD FOR MANUFACTURING AZOLYLMETHYLCYCLOPENTANOL COMPOUND, AND INTERMEDIATE COMPOUND - In order to produce an intermediate from which a cyclic alcohol compound can be stereoselectively obtained, a method for producing an oxetane compound according to the present invention includes the step of reacting, with a cyanide salt, a compound represented by Formula (I): | 2014-05-08 |
20140128612 | DEUTERATED OMEGA DIPHENYLUREA RELATED COMPOUNDS AND INTERMEDIATES - Methods and processes for preparation and production of deuterated ω-diphenylurea are disclosed. Especially, a kind of deuterated ω-diphenylurea compounds which can inhibit phosphokinase and the preparation method of N-(4-chloro-3-(trifluoromethyl)phenyl)-N′-(4-(2-(N-d3-methylcarbamoyl)-4-pridinyloxy)phenyl)urea are disclosed. The said deuterated diphenylurea compounds can be used for treating or preventing tumors and relative diseases. | 2014-05-08 |
20140128613 | A PROCESS FOR PREPARATION OF INTERMEDIATES OF DONEPEZIL HYDROCHLORIDE - The present invention provides a process for the preparation of key intermediate for the synthesis 5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1-indanone hydrochloride (donepezil hydrochloride). The present invention particularly provides a process for the preparation of 5,6-dimethoxy-2-(4-pyridylmethylene)-1-indanone comprising condensation of 5,6-dimethoxy-1-indanone with 4-pyridinecarboxaldehyde using an alkali metal hydroxide as a mild base in the presence of demineralized water as a solvent at a temperature in the range of 15° C. to 45° C. to yield 5,6-dimethoxy-2-(4-pyridylmethylene)-1-indanone, which is subsequently benzylated using benzyl bromide in the presence of solvent at a reflux temperature to yield 1-benzyl-4-[(5,6-dimethoxy-1-indanone-2-yl)methylene]pyridinium bromide. | 2014-05-08 |
20140128614 | PESTICIDAL DIARYL - HETEROCYCLYL DERIVATIVES - To provide pesticidal allylAryl heterocycle derivatives that are useful as a pesticidal compound. | 2014-05-08 |
20140128615 | Preservation Of Ergothioneine - Compositions comprising ergothioneine and a trimethylamine absorber are provided. Also provided are methods for preventing, reducing or minimizing the fishy, amine odor, due to trimethylamine, that is associated with the processing and/or storage of a preparation containing ergothioneine, by combining with the ergothioneine, during processing or prior to storage, a trimethylamine absorber in an amount sufficient to prevent the detection of any trimethylamine odor by the human nose. A method is further provided for ameliorating the methylamine odor associated with an aqueous ergothioneine-containing preparation after it has developed a fishy trimethylamine odor. | 2014-05-08 |
20140128616 | OXYGEN-SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS - The present invention relates to compounds of the formula I, wherein A, D, E, G, R | 2014-05-08 |
20140128617 | METHOD FOR PRODUCING PYRAZOLYLCARBOXANILIDES - The present invention relates to a simplified process for preparing pyrazolylcarboxanilides by reacting pyrazolylcarboxylic esters with anilines in the presence of a base and removing at least one reaction product. | 2014-05-08 |
20140128618 | DIKETOPYRROLOPYRROLE OLIGOMERS FOR USE IN ORGANIC SEMICONDUCTOR DEVICES - The present invention relates to oligomers of the formula (I), and their use as organic semiconductor in organic devices, especially in organic photovoltaics (solar cells) and photodiodes, or in a device containing a diode and/or an organic field effect transistor. High efficiency of energy conversion, excellent field-effect mobility, good on/off current ratios and/or excellent stability can be observed, when the oligomers according to the invention are used in organic field effect transistors, organic photovoltaics (solar cells) and photodiodes. | 2014-05-08 |
20140128619 | Intermediates Useful in the Preparation of Maleimide Functionalized Polymers - Methods for forming maleimide functionalized polymers are provided. In one such embodiment, a maleimide functionalized polymer is prepared in a method that includes a step of carrying out a reverse Diels-Alder reaction. Intermediates useful in the methods, as well as methods for preparing the intermediates, are also provided. Also provided are polymeric reagents, methods of using polymeric reagents, compounds and conjugates. | 2014-05-08 |
20140128620 | PROCESS FOR THE PREPARATION OF ALKYLENE GLYCOL - The invention provides a process for the preparation of an alkylene glycol from an alkene. A gas composition from an alkylene oxide reactor is supplied to an alkylene oxide absorber comprising a column of vertically stacked trays or comprising a packed column. Lean absorbent comprising at least 20 wt % water is supplied to the alkylene oxide absorber and is contacted with the gas composition in the presence of one or more catalysts that promote carboxylation and hydrolysis. At least 50% of the alkylene oxide entering the alkylene oxide absorber is converted in the alkylene oxide absorber. Fat absorbent is withdrawn from the absorber, is optionally supplied to finishing reactors and/or a flash vessel or light ends stripper, and is subsequently subjected to dehydration and purification to provide a purified alkylene glycol product stream. | 2014-05-08 |
20140128621 | THERMOSETTING RESIN COMPOSITION, EPOXY RESIN MOLDING MATERIAL, AND POLYVALENT CARBOXYLIC ACID CONDENSATE - The epoxy resin molding material of the invention comprises (A) an epoxy resin and (B) a curing agent, wherein the (B) curing agent contains a polyvalent carboxylic acid condensate. The thermosetting resin composition of the invention comprises (A) an epoxy resin and (B) a curing agent, wherein the viscosity of the (B) curing agent is 1.0-1000 mPa·s at 150° C., as measured with an ICI cone-plate Brookfield viscometer. | 2014-05-08 |
20140128622 | Process for the Oxidation of Organic Carbonyl Compounds - A process for the oxidation of an organic carbonyl compound comprising reacting the organic carbonyl compound, optionally in the presence of a solvent, with hydrogen peroxide in the presence of a catalyst comprising a tin-containing zeolitic material having an MWW-type framework structure. | 2014-05-08 |
20140128623 | Method of Synthesizing Low Color Furan Diesters - The present invention relates to a method of synthesizing a low colored furan-2,5-dicarboxylate derivative plasticizer by utilizing purified FDCA (pFDCA), which has very low level 5-formyl furan-2-carboxyic acid (FFCA) and very low level colored bodies, and an alcohol. | 2014-05-08 |
20140128624 | METHOD OF SYNTHESIZING LOW COLOR FURAN DIESTERS - The present invention relates to a method of making low colored bis(2-ethylhexyl) furan-2,5-dicarboxylate (BEHFD) plasticizer via mild hydrogenation of highly colored BEHFD. | 2014-05-08 |
20140128625 | METHOD OF PREPARING FURFURAL COMPOUNDS - Provided is a two-step method of producing a compound of chemical formula 1 in the presence of an alcohol solvent and a Group 3B metal catalyst or a salt thereof, comprising a first step comprising alkylation or isomerization of an aldohexose-containing substrate to obtain an intermediate, and a second step comprising dehydration of the intermediate to produce a compound of chemical formula 1. Preferably, additional solvent and/or catalyst are not added in the second step. | 2014-05-08 |
20140128626 | Ionic Liquids For Agricultural Residue Removal - A method of reducing the proportion of agricultural residues (ARs), such as pesticides and herbicides, present in an essential oil, comprising the treatment of the oil with an ionic liquid that has at most limited solubility in the oil, the ionic liquid having an anion and a cation chosen from the following table: | 2014-05-08 |
20140128627 | New SMB Process - The present invention provides a chromatographic separation process for recovering a polyunsaturated fatty acid (PUFA) product from a feed mixture, which process comprises the steps of: (i) purifying the feed mixture in a first separation step in a simulated or actual moving bed chromatography apparatus having a plurality of linked chromatography columns containing, as eluent, an aqueous organic solvent, to obtain an intermediate product; and (ii) purifying the intermediate product obtained in (i) in a second separation step using a simulated or actual moving bed chromatography apparatus having a plurality of linked chromatography columns containing, as eluent, an aqueous organic solvent, to obtain the PUFA product; wherein (a) the first and second separation steps are carried out sequentially on the same chromatography apparatus, the intermediate product being recovered between the first and second separation steps and the process conditions in the chromatography apparatus being adjusted between the first and second separation steps such that the PUFA product is separated from different components of the feed mixture in each separation step; or (b) the first and second separation steps are carried out on separate first and second chromatography apparatuses respectively, the intermediate product obtained from the first separation step being introduced into the second chromatography apparatus, and the PUFA product being separated from different components of the feed mixture in each separation step. | 2014-05-08 |
20140128628 | PROCESS FOR PRODUCTION OF CYCLIC SILANE COMPOUND AND/OR CYCLIC CARBOSILANE COMPOUND - A process for producing a cyclic silane compound, in which a chained polysilane is subjected to pyrolysis in the presence of an oxide of a transition metal belonging to Group 8 or Group 11 of the periodic table; and a process for producing a cyclic carbosilane compound, that includes subjecting a chained polysilane to pyrolysis in the presence of a simple substance of a metal selected from the group consisting of transition metal elements and elements belonging to Groups 12 to 15 of the periodic table, or a compound thereof. | 2014-05-08 |
20140128629 | PHOSPHONIUM SALTS AND METHODS OF THEIR PREPARATION - Methods for preparing phosphonium salts by reacting a primary phosphine or a secondary phosphine with an ester compound selected from the group consisting of: a phosphate triester; a phosphonate diester; a sulfate diester; and a sulfonate ester; to form a phosphonium salt of formula VII | 2014-05-08 |
20140128630 | PHOSPHONIUM SALTS AND METHODS OF THEIR PREPARATION - Methods for preparing phosphonium salts by reacting a primary phosphine or a secondary phosphine with an ester compound selected from the group consisting of: a phosphate triester; a phosphonate diester; a sulfate diester; and a sulfonate ester; to form a phosphonium salt of formula VII | 2014-05-08 |
20140128631 | PROCESS FOR THE PREPARATION OF ALKANOIC ACID ESTERS IN A CARBONYLATION PROCESS USING PALLADIUM BIDENTATE BIPHOSPHATE LIGANDS - The invention relates to a carbonylation process for the preparation of an alkanoic acid ester comprising reacting:
| 2014-05-08 |
20140128632 | CATALYST FOR SINGLE STEP CONVERSION OF GLYCEROL TO ACRYLIC ACID AND PROCESS FOR THE PREPARATION THEREOF - The present invention provides a process and a solid catalyst for oxydehydration of glycerol to acrylic acid with H | 2014-05-08 |
20140128633 | COMPOSITIONS CONTAINING NITRO FATTY ACIDS - Compositions, dietary supplement compositions, and topical compositions including activated fatty acids and methods for using activated fatty acids to treat a variety of diseases. | 2014-05-08 |
20140128634 | PROCESS TO PREPARE LEVULINIC ACID - The invention describes processes to prepare levulinic acid, formic acid and/or hydroxymethyl furfural from various biomass materials. | 2014-05-08 |
20140128635 | TRANSFORMANT FOR PRODUCTION OF LACTIC ACID OF HIGH OPTICAL PURITY AND METHOD FOR PRODUCING LACTIC ACID USING THE SAME - Disclosed is the biological production of lactic acid using a microorganism. A transformant capable of producing lactic acid of high optical purity at high yield, a method for the preparation thereof, and a method for producing lactic acid in a convenient and economically beneficial manner using the same are provided. The | 2014-05-08 |
20140128636 | Processes for Producing Acrylic Acids and Acrylates - In one embodiment, the invention is to a process for producing an acrylate product. The process comprises the step of providing a crude product stream comprising the acrylate product and an alkylenating agent. The process further comprises the step of separating at least a portion of the crude product stream to form an alkylenating agent stream and an intermediate product stream. The alkylenating agent stream comprises at least 1 wt % alkylenating agent and the intermediate product stream comprises acrylate product. | 2014-05-08 |
20140128637 | ATROPISOMERIC 1,8-BISPHENOLNAPTHALENES AND THEIR USE IN ENANTIOSELECTIVE RECOGNITION AND ASYMMETRIC SYNTHESIS - This invention related to atropisomeric 1,8-bisphenolnaphthalenes and derivatives thereof of the general formula (I): | 2014-05-08 |
20140128638 | PROCESS FOR PREPARING AROMATIC AMINES - The invention relates to a process for the continuous preparation of aromatic amines by hydrogenation of the corresponding nitroaromatics in the presence of catalysts arranged in reaction spaces, in which an adiabatically operated reaction space RA is connected downstream of an isothermally operated reaction space RI and RA additionally also has a separate feed for the nitroaromatic to be hydrogenated, RI is fed with the nitroaromatic to be hydrogenated from the start to the end of the hydrogenation, and the product mixture emerging from RI is fed into RA from the start to the end of the hydrogenation, wherein RA can additionally be fed via the separate feed with the nitroaromatic to be hydrogenated. | 2014-05-08 |
20140128639 | METHODS FOR CONVERSION OF A GLYCOL REACTION PRODUCT OBTAINED FROM HYDROTHERMAL DIGESTION OF CELLULOSIC BIOMASS SOLIDS INTO A DRIED MONOHYDRIC ALCOHOL FEED - Hydrothermal digestion of cellulosic biomass solids may produce a glycol reaction product for subsequent processing. Methods for digesting cellulosic biomass solids to form and process a glycol reaction product may comprise: providing cellulosic biomass solids and a slurry catalyst in a hydrothermal digestion unit, the slurry catalyst being capable of activating molecular hydrogen; heating the cellulosic biomass solids in the hydrothermal digestion unit in the presence of the slurry catalyst, a digestion solvent, and molecular hydrogen, thereby forming a liquor phase comprising soluble carbohydrates; performing a first catalytic reduction reaction on the soluble carbohydrates within the hydrothermal digestion unit, thereby at least partially converting the soluble carbohydrates into a reaction product comprising a glycol; at least partially drying the reaction product, thereby forming a dried reaction product comprising a dried glycol; and at least partially converting the dried glycol into a monohydric alcohol external to the hydrothermal digestion unit. | 2014-05-08 |
20140128640 | METHOD OF MAKING GLYCEROL - Method of producing glycerol that includes mixing a peroxide stream with an olefenic alcohol stream to form a feed stream; processing the feed stream in a high shear device to produce a high shear dispersion of peroxide and olefinic alcohol, wherein the high shear device is configured with a rotor and a stator separated by a shear gap; and contacting the high shear dispersion with a catalyst in a reactor to produce glycerol. | 2014-05-08 |
20140128641 | Process for Recovering Ethanol - Recovery of ethanol from a crude ethanol product obtained from the hydrogenation of acetic acid. Separation and purification processes of the crude ethanol products are employed to allow recovery of ethanol and remove impurities. | 2014-05-08 |
20140128642 | Process for Vapor Phase Hydrogenation - A process for selective formation of ethanol from acetic acid includes contacting a feed stream containing acetic acid and hydrogen at an elevated temperature with catalyst comprising platinum and tin on a high surface area silica promoted with calcium metasilicate. Selectivities to ethanol of over 85% are achieved at 280° C. with catalyst life in the hundreds of hours. | 2014-05-08 |
20140128643 | CATALYST FOR THE OXYCHLORINATION OF ETHYLENE TO 1, 2-DICHLOROETHANE - This invention relates to a catalyst containing from about 2 up to about 8% by wt. of copper, zero up to about 0.6 moles/kg of one or more alkali metal(s), from about 0.08 up about 0.85 moles/kg of one or more alkaline earth metals and from about 0.09 up to about 0.9 moles/kg of one or more transition metals selected from the group consisting of Mn, Re and mixtures thereof, where all the metals are impregnated in form of their chlorides or other water soluble salts on a fluidizable support with a BET surface area of from about 80 up to about 220 m | 2014-05-08 |
20140128644 | HIGH OCTANE UNLEADED AVIATION GASOLINE - An unleaded aviation fuel blend. The fuel blend is provided by blending an unleaded aviation gasoline base fuel which may include iso-octane and iso-pentane, and an effective amount of a selected alkyl benzene to improve the functional engine performance to avoid harmful detonation sufficient to meet or exceed selected standards for detonation performance requirements in full scale aircraft piston spark ignition engines designed for use with Grade 100LL avgas. Advantageous alkylated benzenes include those having a meta-ring position between alkyl groups. Alkyl groups may be provided at least in part by methyl groups. In an embodiment, the alkyl benzene may include 1,3-dimethylbenzene. In an embodiment, two or more alkylated benzenes may be provided. In an embodiment, 1,3,5-trimethylbenzene may be provided. Suitable alkylated benzenes may include a mixture of xylene isomers. Selected aromatic amines, such as m-toluidine, may also be added to increase motor octane number. | 2014-05-08 |
20140128645 | ENHANCED PRODUCTION OF ISOPRENE USING MARINE BACTERIAL CELLS - The invention provides for methods for the production of isoprene in recombinant marine bacterial cells via the heterologous expression of isoprene synthase enzymes. | 2014-05-08 |
20140128646 | PROCESS FOR PRODUCING LIQUID HYDROCARBON - The invention relates to a continuos process for converting carbonaceous material contained in one or more feedstocks into a liquid hydrocarbon product, said feedstocks including the carbonaceous material being in a feed mixture including one or more fluids, said fluids including water and further liquid organic compounds at least partly produced by the process in a concentration of at least 1% by weight, where the process comprises converting at least part of the carbonaceous material by pressurising the feed mixture to a pressure in the range 250-400 bar; heating the feed mixture to a temperature in the range 370-450° C., and maintaining said pressurized and heated feed mixture in the desired pressure and temperature ranges in a reaction zone for a predefined time; cooling the feed mixture to a temperature in the range 25-200° C. and expanding the feed mixture to a pressure in the range of 1-70 bar, thereby causing the carbonaceous material to be converted to a liquid hydrocarbon product and separating from the converted feed mixture a fraction comprising liquid hydrocarbon product. | 2014-05-08 |
20140128647 | METHOD AND APPARATUS FOR REDUCING AN AROMATIC CONCENTRATION IN A HYDROCARBON STREAM - Methods and apparatuses for reducing an aromatic concentration in a hydrocarbon stream are provided. In an embodiment, a method for reducing an aromatic concentration in a hydrocarbon stream includes saturating aromatics in the hydrocarbon stream to form a low aromatic hydrocarbon stream comprising no more than about 2 weight percent (wt %) aromatics. Further, the method includes passing the low aromatic hydrocarbon stream through an adsorption zone to remove aromatics therefrom to form an aromatic-depleted product stream comprising less than about 10 weight parts per million (wppm) aromatics. | 2014-05-08 |
20140128648 | HYDROCARBON CONVERSION PROCESS IN THE PRESENCE OF AN ACIDIC IONIC LIQUID WITH UPSTREAM HYDROGENATION - The present invention relates to a process for hydrocarbon conversion in the presence of an acidic ionic liquid. The hydrocarbon conversion is preferably an isomerization, especially an isomerization of methylcyclopentane (MOP) to cyclohexane. Prior to the hydrocarbon conversion, a hydrogenation is performed, preference being given to hydrogenating benzene to cyclohexane. The cyclohexane obtained in the hydrogenation and/or isomerization is preferably isolated from the process. In a preferred embodiment of the present invention, the hydrogenation is followed and the hydrocarbon conversion, especially the isomerization, is preceded by distillative removal of low boilers, especially C | 2014-05-08 |
20140128649 | METHODS AND APPARATUSES FOR ISOMERIZATION OF PARAFFINS - Embodiments of methods and apparatuses for isomerization of paraffins are provided. In one example, a method comprises the steps of compressing a C | 2014-05-08 |
20140128650 | RENEWABLE OLEFINS FROM A MIXTURE OF ACETIC ACID AND PROPIONIC ACID - A process is described for making a product mixture including isobutene, propylene, 1-butene, 2-butene 2-methyl-1-butene and 2-methyl-2-butene from a mixture of acetic acid and propionic and through reaction in the presence of a source of hydrogen and of a mixed oxide catalyst, for example, a Zn | 2014-05-08 |
20140128651 | Process for the Reduction of Alkylation Catalyst Deactivation Utilizing Low Silica to Alumina Ratio Catalyst - Alkylation systems and methods of minimizing alkylation catalyst regeneration are described herein. The alkylation systems generally include a preliminary alkylation system adapted to receive an input stream including an alkyl aromatic hydrocarbon and contact the input stream with a preliminary alkylation catalyst disposed therein to form a first output stream. The preliminary alkylation catalyst generally includes a zeolite catalyst having a SiO | 2014-05-08 |
20140128652 | METHOD FOR PRODUCING DIISOBUTYLENE USING MIXED C4 FRACTION AS RAW MATERIAL - There is provided a process for producing high-purity diisobutylene with a high reaction selectivity in which a mixed C4 fraction is contacted with an oligomerization catalyst to subject isobutene to oligomerization at one stage. The present invention relates to a process for producing diisobutylene by contacting a mixed C4 fraction as a raw material with a solid acid catalyst, which includes the steps of (a) isobutene oligomerization; (b) subjecting the resulting reaction products to distillation to separate the unreacted C4 fraction and an oligomer fraction including a C8 fraction produced from each other; and (c) purification of diisobutylene from the C8 fraction by distillation, in which a conversion of isobutene contained in the mixed C4 fraction upon conducting the step (a) is controlled to a range of from 60 to 95%. | 2014-05-08 |
20140128653 | Catalyst for Selective Dehydrogenation / Oxidative Dehydrogenation Reactions and Process for the Preparation Thereof - The present invention provides a process and catalyst for the direct and selective conversion of ethane to ethylene. The process provides a direct single step vapor phase selective dehydrogenation/oxidative dehydrogenation of ethane to ethylene over Mo supported nanocrystalline TiO | 2014-05-08 |
20140128654 | Reactor and Alkylation Process Using the Reactor - The present disclosure provides a reactor for at least two liquid materials, comprising an enclosed reactor housing; a feeding tube having liquid material inlets for receiving corresponding liquid materials respectively; a distribution tube communicating with the feeding tube and extending into the reactor housing, the distribution tube being provided with a plurality of distribution holes in the region thereof extending into the reactor housing; a rotating bed in form of a hollow cylinder, which is disposed in the reactor housing via a fixing mechanism, thus dividing inner cavity of the reactor housing into a central area and an outer area, the rotating bed being capable of rotating driven by a driving mechanism; and a material outlet provided in a lower portion of the reactor housing for outputting product after reaction. The distribution tube extends into the central area spaced from inner surface of the rotating bed, so that materials can enter into the outer area from the central area through the rotating bed and can be output via the material outlet. | 2014-05-08 |
20140128655 | ISOBARIC PRESSURE EXCHANGER IN AMINE GAS PROCESSING - A system includes an amine gas processing system that includes a contactor configured to remove an acid gas from an untreated natural gas using an amine in a lean amine stream, output a treated natural gas, and output a rich amine stream. The system also includes a regenerator configured to regenerate the amine in the rich amine stream, output the lean amine stream, and output the acid gas. The system also includes an isobaric pressure exchanger (IPX) configured to transfer the rich amine stream from the contactor to the regenerator and to transfer the lean amine stream from the regenerator to the contactor. | 2014-05-08 |
20140128656 | ISOBARIC PRESSURE EXCHANGER CONTROLS IN AMINE GAS PROCESSING - A system includes an amine gas processing controller that includes one or more tangible, non-transitory, machine-readable media collectively storing one or more sets of instructions and one or more processing devices configured to execute the one or more sets of instructions to operate a contactor to remove an acid gas from an untreated natural gas using an amine in a lean amine, output a treated natural gas, and output a rich amine stream, operate a regenerator to regenerate the amine in the rich amine stream, output the lean amine stream, and output the acid gas, transfer the rich amine stream from the contactor to the regenerator using an isobaric pressure exchanger (IPX), and transfer the lean amine stream from the regenerator to the contactor using the IPX. | 2014-05-08 |
20140128657 | PROCESSING OF ELECTRONIC WASTE WITH SUPERCRITICAL NOBLE GASES - A method of processing a material, the method including infiltrating a first disintegration fluid into a material at a first pressure, the first disintegration fluid including at least one supercritical noble gas, the first pressure being higher than a critical pressure of the first disintegration fluid, and disintegrating the material into particles by depressurizing the material from the first pressure to a second pressure, the second pressure being lower than the critical pressure of the first disintegration fluid. | 2014-05-08 |
20140128658 | ENRICHED 10-BORON COMPOSITION FOR CANCER THERAPY AND A METHOD OF SYNTHESIZING THE SAME - The embodiments herein provide a method of synthesizing a novel enriched 10-boron drug for treatment of cancer by Boron Neutron Capture Therapy (BNCT) method. In BNCT, drug containing enriched 10-Boron has the important role in final treatment efficiency. The composition is Enriched 10-Boron Calcium Fructo Borate (E | 2014-05-08 |
20140128659 | SYSTEMS AND METHODS FOR FLUID FLOWS AND/OR PRESSURES FOR CIRCULATION AND PERFUSION ENHANCEMENT - Fluid pressure or flow in a human body may be adjusted with circulation or perfusion systems and methods. The system may include a first pump implantable in a chamber or vessel of the human body, and a plurality of struts connected to a housing of said first pump, wherein said struts secure the first pump in a desired location of said chamber or vessel. The system may also include one or more flow modification elements disposed on said first pump, where said flow modification elements direct flow to a desired organ or a desired vessel to adjust pressure or flow as desired. | 2014-05-08 |
20140128660 | HARD-WIRED IMPLANTED CONTROLLER SYSTEM - A circulatory assist system is disclosed, the system including an implantable electrical device having an electric motor, an implantable controller connected to the implantable electrical device, and an implantable power source connected to the controller for supplying power to the controller. The controller is attachable to a first side of a percutaneous connector. A second side of the percutaneous connector, opposite to the first side, allows external connectivity to said controller. | 2014-05-08 |
20140128661 | MRI Safe Actuator for Implantable Floating Mass Transducer - A floating mass transducer has a cylindrical transducer housing within which is a cylindrical transducer magnet arrangement with a magnetic pair of: i. an inner rod magnet disposed along the cylinder axis with a first magnetic field direction, and ii. an outer annular magnet surrounding the inner rod magnet along the cylinder axis with a second magnetic field direction opposite to the first magnetic field direction. Current flow through the drive coils creates a coil magnetic field that interacts with the magnetic fields of the transducer magnet arrangement to create vibration in the transducer magnet which is coupled by the transducer housing to the middle ear hearing structure for perception as sound. In addition, the opposing magnetic fields of the transducer magnet arrangement cancel each other to minimize their combined magnetic field and thereby minimize magnetic interaction of the transducer magnet arrangement with any external magnetic field. | 2014-05-08 |
20140128662 | MALE INCONTINENCE TREATMENT SYSTEM - An incontinence treatment system for a male patient includes a support, a brace attachable to the support, and an introducer provided to deliver an anchor through the support and into periosteum tissue over a pubic bone of the pelvis of the male patient. The brace includes a base portion, a first post extending from the base portion and a second post extending from the base portion. A first hanger is attached to an end portion of the first post and a second hanger attached to an end portion of the second post. A first slot is formed between the end portion of the first post and the first hanger and a second slot formed between the end portion of the second post and the second hanger. The hangers are insertable into pockets formed in a pair of longitudinal arms of the support. | 2014-05-08 |
20140128663 | PELVIC IMPLANT WITH SUSPENDING SYSTEM - A urethral stabilization system includes a suspending member attached between a stabilizer and support member. The support member is implantable into a patient to support a urethra. A first suspending member is attached between a first end of the support member and a first stabilizer, and a second suspending member is attached between a second end of the support member and a second stabilizer. A first thread member continuously extends between a first end that is attached to the first stabilizer and a second end of the first thread member that is free, and a second thread member continuously extending between a first end that is attached to the second stabilizer and a second end of the second thread member that is free. | 2014-05-08 |
20140128664 | ADJUSTABLE TENSION INCONTINENCE SLING ASSEMBLIES - Systems for providing support to body tissue to alleviate incontinence are disclosed that comprise an elongated incontinence sling having a central support portion adapted to be positioned to support any one of the urethra or anus and first and second sling end portions extending from the central support portion through body tissue and a tension adjustment mechanism acting on or within one or both of the sling end portions. The sling tension adjustment mechanism comprises one or more of a sling tensioning suture or band, a tensioning device coupled to a suture or band free end, a tissue anchor coupled to one or more of a suture free end and a sling end, a mesh fold, a suture tube, and a sling sheath in various combinations. | 2014-05-08 |
20140128665 | INCONTINENCE TREATMENT DEVICE INCLUDING NON-POROUS SUB-URETHRAL SLING - An incontinence treatment device includes a non-porous sling located between two anchors. A first line is attached between a first end of the sling and the first anchor, and a second line is attached to a second end of the sling and inserted through a channel of the second anchor. The second anchor is provided with a restrictor segment provided in the channel. The second line has an adjustment device attached to the second line and the restrictor segment is configured to resist movement of the adjustment device through the channel. The adjustment device is movable through the channel from a first position that locates the adjustment device between the second anchor and the sling to a second position that locates the second anchor between the adjustment device and the sling to thereby reduce an effective length of the sling between the first and second anchors. | 2014-05-08 |
20140128667 | ADAPTIVE EMBRYO SELECTION CRITERIA OPTIMIZED THROUGH ITERATIVE CUSTOMIZATION AND COLLABORATION - The present invention relates to a system and a method for determining quality criteria in order to select the most viable embryos after in vitro fertilization. The present invention may further be applied for iteratively adapting embryo quality criteria based on new knowledge, historical selection & fertilization data and cooperation between fertility clinics. | 2014-05-08 |
20140128668 | DEVICES AND METHODS FOR ENDOLUMENAL WEIGHT LOSS TREATMENTS - Devices and methods for forming and securing tissue folds, elongated invaginations, and tissue appositions in stomach tissue are used as a treatment for obesity. In a first embodiment, a plurality of tissue folds is formed in the fundus region of the stomach. In a second embodiment, one or more elongated invaginations are formed in the body region and/or antrum of the stomach. In a third embodiment, a plurality of tissue folds is formed in the fundus region of the stomach and one or more elongated invaginations is formed in the body region and/or antrum of the stomach. In other embodiments, a plurality of tissue folds is formed in the fundus region of the stomach and one or more tissue appositions are formed in the body region and/or antrum of the stomach. Additional embodiments include various combinations of tissue folds, elongated invaginations, tissue appositions, and other reconfigurations of stomach tissue. | 2014-05-08 |